Page last updated: 2024-08-16

rivastigmine and Dementia

rivastigmine has been researched along with Dementia in 134 studies

Research

Studies (134)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.75)	18.2507
2000's	75 (55.97)	29.6817
2010's	51 (38.06)	24.3611
2020's	7 (5.22)	2.80

Authors

Authors	Studies
Aparasu, RR; Chatterjee, S; Chen, H; Johnson, ML; Masurkar, PP; Sherer, JT	1
Barr, PG; Rajkumar, AP; Storr, NJ; Watts, KE	1
Hughes, C; Lim, WY; Loy, C; McGuinness, B; Parsons, C; Passmore, P; Ward, SA	1
Achten, E; Beun, S; Clement, P; Moyaert, P	1
Barthold, D; Drabo, EF; Ferido, P; Gray, SL; Joyce, G; Marcum, ZA; Zissimopoulos, J	1
Alsabbagh, MW; Huang, Y	1
Mori, K; Nakamura, M; Tomita, K; Yoshida, M; Yoshimura, T	1
Goebert, D; Guilloux, A; Higa, J; Lu, BY; Schultz, BR; Takeshita, J; Takeshita, S	1
Ampil, E; Christopher, S; Kandiah, N; Karanam, AK; Looi, I; Pai, MC; Park, KW; Senanarong, V	1
El-Saifi, N; Jones, C; Moyle, W; Tuffaha, H	1
Bradley, J; Chan, P; Herrmann, N; Lanctôt, K; Mohammad, D	1
Kratz, T	1
François, M; Pelletier Fleury, N; Sicsic, J	1
Buckley, N; Le Couteur, DG; Litchfield, M; McLachlan, AJ; Narayan, SW; Pearson, SA; Zoega, H	1
Bernal-Cobo, R; Calvo-Torres, LF; Gaviria-Mendoza, A; Machado-Alba, JE; Trujillo-Quintero, PM	1
Chauhan, MK; Sharma, PK	1
Johnell, K; Sonde, L	1
Arizaga, RL; Demey, I; Rojas, G	1
Cumbo, E; Ligori, LD	1
Azulay, JP; Bordet, R; Defebvre, L; Defer, G; Delliaux, M; Destée, A; Devos, D; Duhamel, A; Dujardin, K; Eusebio, A; Kreisler, A; Krystkowiak, P; Lefaucheur, R; Maltête, D; Moreau, C; Ouk, T; Witjas, T	1
Khan, KA; Krishnadas, N; Kumar, N; Mudgal, J; Nampoothiri, M; Nayak, PG; Rao, CM; Shenoy, RR	1
Shoji, M	1
Fujii, M; Sasaki, H	1
Chang, HA; Hsu, CC; Kao, YC; Ku, SC; Tzeng, NS	1
Bolle, N; Bucik, V; Kobal, J; Sešok, S; Vodušek, DB	1
Chukhlovina, ML	1
Eichler, T; Hertel, J; Hoffmann, W; Kilimann, I; Michalowsky, B; Teipel, S; Thyrian, JR; Wucherer, D	1
Darreh-Shori, T; Lane, RM	1
Bozoglu, E; Cintosun, U; Doruk, H; Kocak, N; Naharci, MI; Ozturk, A; Tasci, I; Yasar, H	1
Hsieh, CY; Iwata, I; Kao Yang, YH; Lai, EC; Setoguchi, S; Wong, MB; Zhang, Y	1
Huang, AR; Redpath, CJ; van Walraven, C	1
Heinrich, S; Hertel, J; Hoffmann, W; Meyer, S; Michalowsky, B; Schaefer-Walkmann, S; Thyrian, JR; Wübbeler, M; Wucherer, D	1
Chou, YJ; Chow, LH; Hu, HY; Huang, N; Li, CP; Wang, PN; Wu, CY	1
Abagyan, R; Ali, TB; Chen, WY; Reilly, BM; Schleret, TR	1
Lewis, SJ; Szeto, JY	1
Cantrell, FL; Pchelnikova, JL; Thornton, SL	1
Isik, AT; Soysal, P	1
Dartigues, JF; Fourrier-Réglat, A; Helmer, C; Merliere, Y; Moore, N; Pariente, A	1
Barone, P; Burn, DJ; Hsu, C; Lane, RM; Poewe, W; van Laar, T	1
Albanese, A; Lalli, S	1
Boucher, JM; Charbonneau, C; Dorais, M; LeLorier, J; Lescrauwaet, B; Massoud, F	1
Hasselbalch, SG; Kampmann, JP	1
Binder, C; Camacho, F; Dalziel, W; Herrmann, N; Smyth, S	1
Chitnis, S; Rao, J	1
Bakar, M; Gumustas, O; Parlayan, E; Yulug, B	1
Cantor, MD; Farwell, W; Hernandez, RK; Lawler, EV	1
Chang, HM; Chen, CP; Chen, I; Corrales, MP; Effendy, S; Hia, SB; Lee, JM; Narasimhalu, K; Sim, CH; Tan, EK; Wong, MC; Xue, HL	1
Darreh-Shori, T; Jelic, V	1
Berg, D; Di Santo, A; Gaenslen, A; Gasser, T; Godau, J; Liepelt, I; Schweitzer, KJ	1
Tucker, I	1
Aarsland, D; Brønnick, KS; Meng, X; Olin, JT; Schmitt, FA; Tekin, S	1
Aarsland, D; Meng, X; Olin, JT	1
Burr, O; Dannhardt, V; Oechsner, M; Pöhler, M; Reuter, I; Rosengarten, B; Rosengarten, S	1
Farlow, MR; Meng, X; Olin, JT; Schmitt, FA; Tekin, S	1
Deuschl, G; Förstl, H; Mollenhauer, B; Oertel, W; Storch, A; Trenkwalder, C	1
Duh, MS; Kahler, KH; Lefebvre, P; Mody-Patel, N; Scharre, DW; Vekeman, F	1
Damulin, IV	1
Landau, R	1
Allain-Veyrac, G; Collonnier, C; Jolliet, P; Lebreton, A	1
Kremer, J	1
Anzures-Cabrera, J; Higgins, JP; Sarpatwari, A	1
Anderson, G; Austin, PC; Gill, SS; Gruneir, A; Reimer, CL; Rochon, PA; Seitz, DP	1
Atri, A	1
Leelavathi, M; Rosdinom, R; Suguna, M	1
Fox, C; Maidment, I; McShane, R; Rolinski, M	1
Hägg, S; Jönsson, AK; Lövborg, H	1
Rösler, M	1
Inglis, F	1
Bullock, R; Cameron, A	1
Hartmann, S; Möbius, HJ	1
Fogelson, N; Giladi, N; Kogan, E; Korczyn, AD; Neufeld, MY; Shabtai, H	1
Gandelman-Marton, R; Klein, C; Rabey, JM; Werber, EA	1
Fuchsberger, T; Hampel, H; Möller, HJ	1
Anca, M; Benbunan, B; Giladi, N; Gurevich, T; Korczyn, AD; Shabtai, H	1
Buller, N; Ptok, M; Schwemmle, C; Schwemmle, U	1
Lampl, Y; Lorberboym, M; Sadeh, M	1
Bohiri, Y; Kotler, M; Mendelsohn, E; Rosenthal, M; Strous, RD; Werber, E	1
García-Borreguero, D; Serrano, C	1
Antonello, RM; Bava, A; Cattaruzza, T; Cazzato, G; Moretti, R; Torre, P	1
Aarsland, D; Albanese, A; Byrne, EJ; De Deyn, PP; Deuschl, G; Durif, F; Emre, M; Kulisevsky, J; Lane, R; Lees, A; Poewe, W; Quarg, P; Robillard, A; Rosa, MM; Tekin, S; van Laar, T; Wolters, E	1
Press, DZ	1
Arya, P; Butler, R; Warner, J	2
Boeve, BF	1
Harada, CN; Sachs, GA; Shega, JW	1
Gauthier, S	1
Ellis, JM	1
Cummings, JL	1
Morgan, J; Sethi, KD	1
Desai, AK; Grossberg, GT	1
Lublin, HK; Olsen, CE; Poulsen, HD	1
Emre, M; Hsu, C; Lane, R; Onofrj, M; Poewe, W; Tekin, S; Wolters, E	1
Edgar, C; Emre, M; Lane, R; McKeith, I; Wesnes, KA	1
Burns, A; Olde Rikkert, MG; Oude Voshaar, RC	1
Boustani, M; Fox, C; Maidment, I	1
Blackhouse, G; Goeree, R; McBurney, C; Pullenayegum, EM; Willan, AR	1
Abraham, IL; Deblander, A; MacDonald, KM; Vancayzeele, S	1
Alva, G; Chen, M; Gunay, I; Koumaras, B; Mirski, D; Potkin, SG	1
Butler, R; Warner, J; Wuntakal, B	1
Cummings, JL; Ringman, JM	1
Bernardini, S; Bonuccelli, U; Ceravolo, R; Frosini, D; Kiferle, L; Logi, C; Manca, G; Mariani, G; Murri, L; Rossi, C; Volterrani, D	1
Beck, C; Blank, K; Colenda, CC; Doraiswamy, MP; Kalunian, DA; Lyketsos, CG; Yaffe, K	1
Giladi, N; Gurevich, TY; Korczyn, AD; Shabtai, H; Simon, ES	1
Siddiqui, MA; Wagstaff, AJ	2
Aarsland, D; Burn, D; De Deyn, PP; Emre, M; Hsu, C; Lane, R; McKeith, I	1
Destée, A; Devos, D; Duhem, S; Dujardin, K; Durif, F; Lacomblez, L; Marié, RM; Péré, JJ; Pollak, P; Touchon, J	1
Mollenhauer, B; Trenkwalder, C; Wenzel, S	1
Aarsland, D; Brønnick, K; De Deyn, PP; Ehrt, U; Emre, M; Lane, R; Tekin, S	1
Agrawal, R; Nath, C; Shukla, R; Tyagi, E	1
Antonello, RM; Moretti, R; Pizzolato, G; Torre, P; Vilotti, C	1
Damier, P; Meyniel, C	1
Wesnes, K	1
Baker, AS; Brandt, J; Lyketsos, CG; Mayer, LS; McNabney, M; Onyike, CU; Rosenblatt, A; Samus, QM	1
Anghelescu, I; Heuser, I	1
Cummings, J; Winblad, B	1
Landmark, K; Reikvam, A	2
Kuiper, RB; Lemstra, AW; Schmand, B; van Gool, WA	1
Figiel, G; Sadowsky, C	1
De Deyn, PP; Emre, M; Hsu, C; Kirsch, C; Lane, R; Oertel, W; Poewe, W; Tekin, S; Wolters, E	1
Lee, MR; Padua, Y; Stevens, DL	1
Adelman, A; Campos-Outcalt, D; Cross, JT; Forciea, MA; Hopkins, R; Mehr, D; Owens, DK; Qaseem, A; Santaguida, P; Schellhase, K; Shekelle, P; Snow, V	1
Booker, L; Cowan, D; Ismaila, A; Levine, M; Oremus, M; Patterson, C; Raina, P; Santaguida, P	1
Liao, S; Morrison, LJ	1
Graham, L	1
Schneider, LS	1
Smith, DJ; Yukhnevich, S	1
Anand, R; Cicin-Sain, A; Hartman, R; Korczyn, AD; Rotmensch, HH; Weiser, M	1
Bullock, R	1

Reviews

49 review(s) available for rivastigmine and Dementia

Article	Year
Systematic review of pharmacological interventions for people with Lewy body dementia. Aging & mental health, 2023, Volume: 27, Issue:2 Topics: Alzheimer Disease; Dementia; Humans; Lewy Body Disease; Parkinson Disease; Rivastigmine	2023
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia. The Cochrane database of systematic reviews, 2021, 02-03, Volume: 2 Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Humans; Memantine; Parkinson Disease; Quality of Life; Rivastigmine	2021
Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review. Journal of Alzheimer's disease : JAD, 2023, Volume: 93, Issue:4 Topics: Acetylcholinesterase; Alzheimer Disease; Cerebrovascular Circulation; Cholinesterase Inhibitors; Cognition; Dementia; Galantamine; Humans; Indans; Parkinson Disease; Perfusion; Phenylcarbamates; Piperidines; Rivastigmine	2023
Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review. Pharmacology research & perspectives, 2020, Volume: 8, Issue:4 Topics: Alzheimer Disease; Animals; Arrhythmias, Cardiac; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Rivastigmine	2020
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. Clinical interventions in aging, 2017, Volume: 12 Topics: Acetylcholinesterase; Activities of Daily Living; Alzheimer Disease; Behavioral Symptoms; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognition; Dementia; Dementia, Vascular; Humans; Parkinson Disease; Rivastigmine	2017
Medication Adherence in Older Patients With Dementia: A Systematic Literature Review. Journal of pharmacy practice, 2018, Volume: 31, Issue:3 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Humans; Independent Living; Medication Adherence; Neuroprotective Agents; Rivastigmine	2018
Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation. Expert opinion on drug safety, 2017, Volume: 16, Issue:9 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Drug Interactions; Galantamine; Humans; Indans; Piperidines; Rivastigmine; Severity of Illness Index	2017
The Diagnosis and Treatment of Behavioral Disorders in Dementia. Deutsches Arzteblatt international, 2017, Jun-30, Volume: 114, Issue:26 Topics: Attention Deficit and Disruptive Behavior Disorders; Cholinesterase Inhibitors; Dementia; Galantamine; Humans; Rivastigmine	2017
Drugs for cognitive loss and dementia. Treatment guidelines from the Medical Letter, 2013, Volume: 11, Issue:134 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2013
[Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cholinesterase Inhibitors; Cognitive Dysfunction; Dementia; Disease Progression; Donepezil; Education, Medical, Continuing; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Peptide Fragments; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Reference Standards; Rivastigmine; tau Proteins; Tomography, Emission-Computed, Single-Photon	2014
[Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:7 Topics: Aging; alpha-Synuclein; Aminoquinolines; Cholinergic Neurons; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Male; Mutation; Parkinson Disease; Phenylcarbamates; Protein Kinases; Rivastigmine	2014
Understanding the beneficial and detrimental effects of donepezil and rivastigmine to improve their therapeutic value. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:4 Topics: Acetylcholine; Acetylcholinesterase; Amyloid beta-Peptides; Apolipoproteins E; Butyrylcholinesterase; Cholinesterase Inhibitors; Dementia; Donepezil; Humans; Indans; Microglia; Phenylcarbamates; Piperidines; Rivastigmine	2015
Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia. Current neuropharmacology, 2016, Volume: 14, Issue:4 Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Exercise Therapy; Galantamine; Humans; Indans; Memantine; Parkinson Disease; Piperidines; Rivastigmine; Sleep Wake Disorders; Treatment Outcome	2016
Rivastigmine in Parkinson's disease dementia. Expert review of neurotherapeutics, 2008, Volume: 8, Issue:8 Topics: Brain; Cholinesterase Inhibitors; Dementia; Humans; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine	2008
Rivastigmine in Parkinson's disease dementia. Expert opinion on drug metabolism & toxicology, 2009, Volume: 5, Issue:8 Topics: Aged; Brain Chemistry; Dementia; Drug Approval; Humans; Middle Aged; Neuroprotective Agents; Parasympathetic Nervous System; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Risk Factors; Rivastigmine	2009
Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia. Expert opinion on drug safety, 2010, Volume: 9, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dermatitis, Irritant; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome; Vomiting	2010
Management of inappropriate sexual behaviors in dementia: a literature review. International psychogeriatrics, 2010, Volume: 22, Issue:5 Topics: Aged; Aged, 80 and over; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Humans; Male; Phenylcarbamates; Rivastigmine; Sexual Behavior	2010
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Deutsches Arzteblatt international, 2010, Volume: 107, Issue:39 Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2010
[Rivastigmine in the treatment of dementia: from the symptomatic effect to neuroprotection]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:9 Topics: Cholinesterase Inhibitors; Dementia; Humans; Neuroprotective Agents; Phenylcarbamates; Rivastigmine	2010
First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine? American journal of clinical dermatology, 2011, Jun-01, Volume: 12, Issue:3 Topics: Aged, 80 and over; Buttocks; Cholinesterase Inhibitors; Dementia; Dermatitis, Allergic Contact; Drug Eruptions; Exanthema; Humans; Intertrigo; Male; Phenylcarbamates; Rivastigmine; Syndrome	2011
[Cholinesterase inhibitors for treating dementia. Review]. Vertex (Buenos Aires, Argentina), 2010, Volume: 21 Suppl Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine	2010
Effective pharmacological management of Alzheimer's disease. The American journal of managed care, 2011, Volume: 17 Suppl 13 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Disease Progression; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Time Factors; Treatment Outcome	2011
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. The Cochrane database of systematic reviews, 2012, Mar-14, Issue:3 Topics: Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2012
The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. International journal of clinical practice. Supplement, 2002, Issue:127 Topics: Behavioral Symptoms; Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2002
The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. International journal of clinical practice. Supplement, 2002, Issue:127 Topics: Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2002
[Current therapy of patients with dementia]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dementia; Dementia, Vascular; Donepezil; Dopamine Agents; Female; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Meta-Analysis as Topic; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Placebos; Plant Preparations; Prospective Studies; Rivastigmine; Tacrine; Time Factors	2003
Fluctuations in cognition and alertness in Parkinson's disease and dementia. Neurology, 2004, Oct-26, Volume: 63, Issue:8 Suppl 3 Topics: Awareness; Central Nervous System Stimulants; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Double-Blind Method; Humans; Lewy Body Disease; Melatonin; Multicenter Studies as Topic; Parkinson Disease; Phenylcarbamates; Phototherapy; Randomized Controlled Trials as Topic; Rivastigmine	2004
Dementia. Clinical evidence, 2004, Issue:11 Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E	2004
Cholinesterase inhibitors in the treatment of dementia. The Journal of the American Osteopathic Association, 2005, Volume: 105, Issue:3 Topics: Acetylcholine; Acetylcholinesterase; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cost of Illness; Dementia; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index	2005
Dementia. Clinical evidence, 2004, Issue:12 Topics: Alzheimer Disease; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine	2004
Rivastigmine for Alzheimer's disease. Expert review of neurotherapeutics, 2005, Volume: 5, Issue:5 Topics: Alzheimer Disease; Animals; Cognition Disorders; Dementia; Expert Testimony; Humans; Meta-Analysis as Topic; Models, Biological; Neuroprotective Agents; Phenylcarbamates; Predictive Value of Tests; Randomized Controlled Trials as Topic; Rivastigmine	2005
Drug therapy of dementia in elderly patients. A review. Nordic journal of psychiatry, 2005, Volume: 59, Issue:2 Topics: Aged; Alzheimer Disease; Dementia; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2005
Cholinesterase inhibitors for Parkinson's disease dementia. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Cholinesterase Inhibitors; Dementia; Humans; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine	2006
Longitudinal observational studies to study the efficacy-effectiveness gap in drug therapy: application to mild and moderate dementia. The Nursing clinics of North America, 2006, Volume: 41, Issue:1 Topics: Aged; Attitude to Health; Belgium; Caregivers; Cholinesterase Inhibitors; Cost of Illness; Dementia; Drug Utilization; Evidence-Based Medicine; Family; Geriatric Assessment; Geriatric Nursing; Humans; Longitudinal Studies; Nurse's Role; Observation; Outcome Assessment, Health Care; Pharmacoepidemiology; Phenylcarbamates; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Research Design; Rivastigmine; Severity of Illness Index	2006
Dementia. Clinical evidence, 2005, Issue:14 Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine	2005
Current and emerging pharmacological treatment options for dementia. Behavioural neurology, 2006, Volume: 17, Issue:1 Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2006
Rivastigmine: in Parkinson's disease dementia. CNS drugs, 2006, Volume: 20, Issue:9 Topics: Animals; Cholinesterase Inhibitors; Dementia; Drug Evaluation; Humans; Parkinson Disease; Phenylcarbamates; Rivastigmine	2006
[Diagnosis and clinical therapy for Parkinson's disease]. Der Nervenarzt, 2006, Volume: 77, Issue:12 Topics: Algorithms; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Humans; Mental Status Schedule; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine	2006
Rivastigmine in Parkinson's disease dementia: profile report. Drugs & aging, 2007, Volume: 24, Issue:3 Topics: Aged; Dementia; Humans; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine	2007
[Lewy body dementia and Parkinson disease dementia]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:10 Pt 2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Dementia; Diagnosis, Differential; Disease Progression; Dopamine Agents; Humans; Iatrogenic Disease; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Parkinsonian Disorders; Phenylcarbamates; Psychotropic Drugs; Rivastigmine; Serotonin Antagonists	2007
Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease. Drugs of today (Barcelona, Spain : 1998), 2007, Volume: 43, Issue:6 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting	2007
[Acetylcholinesterase inhibitors for dementia--an update]. MMW Fortschritte der Medizin, 2007, May-21, Volume: 149 Suppl 2 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors	2007
A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia. Expert review of neurotherapeutics, 2007, Volume: 7, Issue:11 Topics: Alzheimer Disease; Dementia; Humans; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine	2007
A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders. Current medical research and opinion, 2008, Volume: 24, Issue:1 Topics: Acetylcholine; Cholinergic Fibers; Dementia; Humans; Mental Disorders; Nervous System Diseases; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Treatment Outcome	2008
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Jan-31, Volume: 128, Issue:3 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome	2008
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
New therapeutic approaches to cognitive impairment. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 11 Topics: Aged; Alzheimer Disease; Antioxidants; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Humans; Indans; Monoamine Oxidase Inhibitors; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Trichlorfon	1998
Understanding changes in cholinergic function: implications for treating dementia. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:3 Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinergic Fibers; Cholinesterase Inhibitors; Dementia; Humans; Lewy Body Disease; Mental Disorders; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Treatment Outcome	2002
The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis. International journal of clinical practice, 2002, Volume: 56, Issue:3 Topics: Aged; Alzheimer Disease; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Dementia; Humans; Neuroprotective Agents; Phenylcarbamates; Rivastigmine	2002

Trials

24 trial(s) available for rivastigmine and Dementia

Article	Year
Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. Journal of Alzheimer's disease : JAD, 2014, Volume: 39, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Longitudinal Studies; Male; Memantine; Mental Disorders; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine	2014
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:6 Topics: Activities of Daily Living; Adult; Aged; Apathy; Cholinesterase Inhibitors; Dementia; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index	2014
Cognitive function in early clinical phase huntington disease after rivastigmine treatment. Psychiatria Danubina, 2014, Volume: 26, Issue:3 Topics: Adult; Cognition Disorders; Dementia; Double-Blind Method; Female; Humans; Huntington Disease; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychometrics; Rivastigmine; Slovenia	2014
Antidementia drug treatment in people screened positive for dementia in primary care. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:3 Topics: Aged; Aged, 80 and over; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Male; Memantine; Mental Status Schedule; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Primary Health Care; Rivastigmine	2015
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Movement disorders : official journal of the Movement Disorder Society, 2008, Aug-15, Volume: 23, Issue:11 Topics: Aged; Analysis of Variance; Dementia; Double-Blind Method; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Mental Status Schedule; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index	2008
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease. Acta neurologica Scandinavica, 2010, Volume: 121, Issue:4 Topics: Aged; Aged, 80 and over; Brain Ischemia; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Double-Blind Method; Executive Function; Female; Humans; Male; Middle Aged; Phenylcarbamates; Pilot Projects; Rivastigmine; Stroke; Treatment Outcome	2010
Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2010, Volume: 6, Issue:1 Topics: Aged; Behavioral Symptoms; Cognition Disorders; Dementia; Female; Humans; Male; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Supranuclear Palsy, Progressive	2010
Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living. Dementia and geriatric cognitive disorders, 2010, Volume: 29, Issue:6 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome	2010
Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia. CNS neuroscience & therapeutics, 2010, Volume: 16, Issue:6 Topics: Aged; Dementia; Double-Blind Method; Executive Function; Female; Humans; Male; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Problem Solving; Reading; Rivastigmine; Thinking; Treatment Outcome	2010
Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients. Acta neurologica Scandinavica, 2003, Volume: 107, Issue:4 Topics: Aged; Aged, 80 and over; Analysis of Variance; Carbamates; Cholinesterase Inhibitors; Dementia; Electroencephalography; Female; Humans; Male; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine	2003
The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:6 Topics: Acetylcholine; Aged; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Electroencephalography; Event-Related Potentials, P300; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Prospective Studies; Reaction Time; Rivastigmine; Tacrine; Treatment Outcome	2003
Rivastigmine (Exelon) for dementia in patients with Parkinson's disease. Acta neurologica Scandinavica, 2003, Volume: 108, Issue:5 Topics: Aged; Carbamates; Cholinesterase Inhibitors; Cognition; Dementia; Humans; Male; Parkinson Disease; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Time Factors; Treatment Outcome	2003
Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living. International clinical psychopharmacology, 2004, Volume: 19, Issue:6 Topics: Activities of Daily Living; Aged; Behavior; Cholinesterase Inhibitors; Chronic Disease; Cognition; Dementia; Female; Humans; Male; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Sex Factors; Treatment Outcome	2004
Rivastigmine in frontotemporal dementia: an open-label study. Drugs & aging, 2004, Volume: 21, Issue:14 Topics: Aged; Caregivers; Dementia; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Rivastigmine; Statistics, Nonparametric; Treatment Outcome	2004
Rivastigmine for dementia associated with Parkinson's disease. The New England journal of medicine, 2004, Dec-09, Volume: 351, Issue:24 Topics: Aged; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting	2004
Rivastigmine for dementia associated with Parkinson's disease. Current neurology and neuroscience reports, 2005, Volume: 5, Issue:4 Topics: Aged; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Middle Aged; Nausea; Neuroprotective Agents; Parkinson Disease; Patient Selection; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Tremor; Vomiting	2005
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:4 Topics: Activities of Daily Living; Aged; Cholinesterase Inhibitors; Cognition; Dementia; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Rivastigmine; Time Factors; Treatment Outcome	2006
Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology, 2005, Nov-22, Volume: 65, Issue:10 Topics: Aged; Aged, 80 and over; Attention; Cognition; Cognition Disorders; Corpus Striatum; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Frontal Lobe; Humans; Male; Middle Aged; Neural Pathways; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Placebos; Reaction Time; Rivastigmine; Treatment Outcome	2005
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia. Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:11 Topics: Aged; Antiparkinson Agents; Brain; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Humans; Image Processing, Computer-Assisted; Indans; Male; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine; Tomography, Emission-Computed, Single-Photon	2006
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: Aged; Aged, 80 and over; Analysis of Variance; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Follow-Up Studies; Hallucinations; Humans; Male; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome	2006
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease. Journal of neurology, 2006, Volume: 253, Issue:9 Topics: Aged; Dementia; Double-Blind Method; Female; Humans; Male; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine	2006
Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:10 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Depressive Disorder; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Psychomotor Disorders; Rivastigmine; Sex Factors	2007
Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension. Drug safety, 2008, Volume: 31, Issue:1 Topics: Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Psychomotor Performance; Remission, Spontaneous; Retrospective Studies; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome; Tremor	2008
A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances. International journal of geriatric psychiatry, 2002, Volume: 17, Issue:4 Topics: Aged; Analysis of Variance; Antipsychotic Agents; Carbamates; Cholinesterase Inhibitors; Dementia; Drug Therapy, Combination; Female; Humans; Male; Phenylcarbamates; Risperidone; Rivastigmine; Social Behavior Disorders	2002

Other Studies

61 other study(ies) available for rivastigmine and Dementia

Article	Year
Risk of overactive bladder associated with cholinesterase inhibitors in dementia. Journal of the American Geriatrics Society, 2022, Volume: 70, Issue:3 Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Humans; Male; Medicare; Muscarinic Antagonists; Retrospective Studies; Rivastigmine; United States; Urinary Bladder, Overactive	2022
Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities. Journal of Alzheimer's disease : JAD, 2020, Volume: 76, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; Female; Galantamine; Healthcare Disparities; Humans; Male; Medicare; Memantine; Nootropic Agents; Patient Acceptance of Health Care; Rivastigmine; Treatment Outcome; United States	2020
Intervention of dementia support team pharmacists and its effects for the proper use of rivastigmine. Die Pharmazie, 2021, 07-01, Volume: 76, Issue:7 Topics: Dementia; Humans; Pharmacists; Rivastigmine	2021
Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2017, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Asian People; Cholinergic Antagonists; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Hawaii; Hospitals, Urban; Humans; Indans; Male; Memantine; Native Hawaiian or Other Pacific Islander; Pacific Islands; Piperidines; Retrospective Studies; Rivastigmine	2017
Drugs for Dementia and Excess of Hospitalization: A Longitudinal French Study. Journal of Alzheimer's disease : JAD, 2018, Volume: 61, Issue:4 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Female; France; Health Expenditures; Hospitalization; Humans; Longitudinal Studies; Male; Rivastigmine	2018
Anticholinergic medicines use among older adults before and after initiating dementia medicines. British journal of clinical pharmacology, 2019, Volume: 85, Issue:9 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Australia; Cholinergic Antagonists; Cholinesterase Inhibitors; Dementia; Deprescriptions; Donepezil; Drug Prescriptions; Female; Humans; Male; Memantine; Middle Aged; Retrospective Studies; Risperidone; Rivastigmine	2019
[Patterns of antidemential drug use in a group of patients from Colombia]. Revista de neurologia, 2019, May-16, Volume: 68, Issue:10 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colombia; Cross-Sectional Studies; Dementia; Donepezil; Drug Utilization; Female; Galantamine; Humans; Male; Memantine; Middle Aged; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2019
Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. Chemistry and physics of lipids, 2019, Volume: 224 Topics: Administration, Cutaneous; Animals; Blood Specimen Collection; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dementia; Drug Liberation; Humans; Lipids; Liposomes; Nanocapsules; Neuroprotective Agents; Rats, Wistar; Rivastigmine; Transdermal Patch	2019
Is drug treatment for dementia followed up in primary care? A Swedish study of dementia clinics and referring primary care centres. PloS one, 2013, Volume: 8, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Medical Records; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Retrospective Studies; Rivastigmine; Sweden; Treatment Outcome	2013
[Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina]. Medicina, 2013, Volume: 73, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Argentina; Child; Child, Preschool; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Dementia, Vascular; Donepezil; Drug Prescriptions; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Middle Aged; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Young Adult	2013
Impact of caffeic acid on aluminium chloride-induced dementia in rats. The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:12 Topics: Aluminum Chloride; Aluminum Compounds; Animals; Caffeic Acids; Chlorides; Cholinesterase Inhibitors; Dementia; Male; Nitrites; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine	2013
Anti-dementia drugs in a psychiatric hospital for dementia patients. Geriatrics & gerontology international, 2014, Volume: 14, Issue:3 Topics: Aged; Dementia; Donepezil; Galantamine; Hospitalization; Hospitals, Psychiatric; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2014
Psychotic episode in a patient with Alzheimer's dementia while shifting from the oral to patch form of rivastigmine. The Journal of neuropsychiatry and clinical neurosciences, 2014,Summer, Volume: 26, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Aged; Dementia; Humans; Male; Phenylcarbamates; Psychotic Disorders; Rivastigmine	2014
Galantamine improves sleep quality in patients with dementia. Acta neurologica Belgica, 2015, Volume: 115, Issue:4 Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Indans; Male; Piperidines; Rivastigmine; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome	2015
Risk of pneumonia in new users of cholinesterase inhibitors for dementia. Journal of the American Geriatrics Society, 2015, Volume: 63, Issue:5 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cohort Studies; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Male; Phenylcarbamates; Piperidines; Pneumonia; Retrospective Studies; Risk Assessment; Rivastigmine	2015
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada. BMC neurology, 2015, Apr-28, Volume: 15 Topics: Aged; Cholinesterase Inhibitors; Comorbidity; Databases, Factual; Dementia; Donepezil; Female; Galantamine; Health Services Research; Humans; Indans; Male; Ontario; Pacemaker, Artificial; Piperidines; Prosthesis Implantation; Retrospective Studies; Risk; Rivastigmine	2015
Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use. BMC health services research, 2015, May-22, Volume: 15 Topics: Aged; Aged, 80 and over; Caregivers; Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; Female; Galantamine; Germany; Humans; Indans; Interviews as Topic; Logistic Models; Male; Memantine; Neuroprotective Agents; Nootropic Agents; Piperidines; Rivastigmine	2015
The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan. PloS one, 2015, Volume: 10, Issue:6 Topics: Cohort Studies; Dementia; Dihydroergocristine; Dihydroergotamine; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Piperidines; Piracetam; Proportional Hazards Models; Retrospective Studies; Rivastigmine; Taiwan; Time Factors	2015
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. PloS one, 2015, Volume: 10, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Alzheimer Disease; Canada; Cholinesterase Inhibitors; Databases, Factual; Dementia; Donepezil; Galantamine; Humans; Indans; Pharmacovigilance; Piperidines; Rivastigmine; United States; United States Food and Drug Administration	2015
Characteristics of Pediatric Exposures to Antidementia Drugs Reported to a Poison Control System. The Journal of pediatrics, 2016, Volume: 172 Topics: Child; Child, Preschool; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Nootropic Agents; Piperidines; Poison Control Centers; Retrospective Studies; Rivastigmine	2016
Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study. The journal of nutrition, health & aging, 2016, Volume: 20, Issue:4 Topics: Acetylcholinesterase; Activities of Daily Living; Aged; Body Mass Index; Body Weight; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Eating; Female; Follow-Up Studies; Galantamine; Geriatric Assessment; Humans; Indans; Male; Nutrition Assessment; Nutritional Status; Piperidines; Polypharmacy; Retrospective Studies; Rivastigmine	2016
Prevalence of cholinesterase inhibitors in subjects with dementia in Europe. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:7 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Europe; Galantamine; Health Policy; Humans; Indans; Insurance, Health, Reimbursement; Phenylcarbamates; Piperidines; Practice Patterns, Physicians'; Prevalence; Rivastigmine	2008
Drug utilization review of cholinesterase inhibitors in Quebec. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2008, Volume: 35, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Utilization Review; Galantamine; Humans; Indans; Middle Aged; Phenylcarbamates; Piperidines; Quebec; Rivastigmine	2008
[Treatment of degenerative dementia disorders--who should be treated?]. Ugeskrift for laeger, 2009, Mar-02, Volume: 171, Issue:10 Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Dopamine Agents; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Lewy Body Disease; Memantine; Middle Aged; Neuroprotective Agents; Parkinson Disease; Patient Selection; Phenylcarbamates; Rivastigmine	2009
Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study. Drugs & aging, 2009, Volume: 26, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Databases, Factual; Delayed-Action Preparations; Dementia; Donepezil; Follow-Up Studies; Galantamine; Humans; Indans; Medication Adherence; Phenylcarbamates; Piperidines; Rivastigmine	2009
Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect. The Journal of neuropsychiatry and clinical neurosciences, 2009,Summer, Volume: 21, Issue:3 Topics: Aged; Aspartic Acid; Brain; Cognition Disorders; Dementia; Donepezil; Female; Humans; Indans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome	2009
Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:11 Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Heart Rate; Hospitals, Veterans; Humans; Incidence; Indans; Massachusetts; Nootropic Agents; Phenylcarbamates; Piperidines; Risk; Rivastigmine; Veterans	2009
Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items. American journal of Alzheimer's disease and other dementias, 2010, Volume: 25, Issue:5 Topics: Cognition; Cognition Disorders; Dementia; Humans; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Retrospective Studies; Rivastigmine; Severity of Illness Index; Treatment Outcome	2010
Neurovascular coupling in Parkinson's disease patients: effects of dementia and acetylcholinesterase inhibitor treatment. Journal of Alzheimer's disease : JAD, 2010, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Case-Control Studies; Cerebral Arteries; Cholinesterase Inhibitors; Dementia; Electroencephalography; Evoked Potentials, Visual; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Photic Stimulation; Rivastigmine; Ultrasonography, Doppler, Color	2010
Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study. Drugs & aging, 2010, Nov-01, Volume: 27, Issue:11 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cohort Studies; Databases, Factual; Dementia; Donepezil; Female; Humans; Indans; Male; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Time Factors	2010
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions: Evidence is not satisfactory. Deutsches Arzteblatt international, 2011, Volume: 108, Issue:8 Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Evidence-Based Medicine; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2011
Expressing findings from meta-analyses of continuous outcomes in terms of risks. Statistics in medicine, 2011, Nov-10, Volume: 30, Issue:25 Topics: Anxiety Disorders; Behavior Therapy; Computer Simulation; Data Interpretation, Statistical; Dementia; Humans; Meta-Analysis as Topic; Neuroprotective Agents; Odds Ratio; Phenylcarbamates; Randomized Controlled Trials as Topic; Risk; Rivastigmine; Sample Size	2011
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011, Volume: 19, Issue:9 Topics: Aged; Aged, 80 and over; Anesthesia, General; Cholinesterase Inhibitors; Cohort Studies; Critical Care; Dementia; Donepezil; Female; Galantamine; Hip Fractures; Humans; Indans; Male; Outcome and Process Assessment, Health Care; Phenylcarbamates; Piperidines; Pneumonia; Postoperative Complications; Respiratory Insufficiency; Resuscitation; Risk; Rivastigmine	2011
Pisa syndrome secondary to rivastigmine: a case report. La Clinica terapeutica, 2012, Volume: 163, Issue:1 Topics: Aged; Benzodiazepines; Cholinesterase Inhibitors; Delusions; Dementia; Donepezil; Humans; Indans; Male; Movement Disorders; Olanzapine; Phenylcarbamates; Piperidines; Posture; Rivastigmine; Syndrome	2012
A fatal outcome after unintentional overdosing of rivastigmine patches. Current drug safety, 2012, Volume: 7, Issue:1 Topics: Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Drug Labeling; Drug Overdose; Fatal Outcome; Humans; Male; Medication Errors; Phenylcarbamates; Rivastigmine; Transdermal Patch	2012
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. Current medical research and opinion, 2002, Volume: 18, Issue:5 Topics: Aged; Carbamates; Cholinesterase Inhibitors; Dementia; Female; Hallucinations; Humans; Male; Parkinson Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome	2002
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. International clinical psychopharmacology, 2003, Volume: 18, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Middle Aged; Phenylcarbamates; Piperidines; Product Surveillance, Postmarketing; Rivastigmine; Surveys and Questionnaires; Tacrine; Treatment Outcome	2003
[Dementia-current knowledge and significance for ENT specialists]. HNO, 2004, Volume: 52, Issue:12 Topics: Aged; Cholinesterase Inhibitors; Comorbidity; Cross-Sectional Studies; Dementia; Germany; Humans; Mental Status Schedule; Middle Aged; Otorhinolaryngologic Diseases; Phenylcarbamates; Prognosis; Randomized Controlled Trials as Topic; Rivastigmine	2004
Efficacy of acetylcholinesterase inhibitors in frontotemporal dementia. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:11 Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2004
Parkinson's disease dementia--a first step? The New England journal of medicine, 2004, Dec-09, Volume: 351, Issue:24 Topics: Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Disease Progression; Humans; Lewy Body Disease; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine	2004
Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease. The Lancet. Neurology, 2005, Volume: 4, Issue:3 Topics: Cholinesterase Inhibitors; Dementia; Humans; Lewy Body Disease; Parkinson Disease; Phenylcarbamates; Rivastigmine	2005
Rivastigmine for dementia associated with Parkinson's disease. The New England journal of medicine, 2005, Mar-31, Volume: 352, Issue:13 Topics: Bias; Cholinesterase Inhibitors; Data Interpretation, Statistical; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting	2005
Drugs for Alzheimer's disease and related dementias. BMJ (Clinical research ed.), 2005, Apr-16, Volume: 330, Issue:7496 Topics: Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Dibenzothiazepines; Humans; Phenylcarbamates; Practice Guidelines as Topic; Quetiapine Fumarate; Rivastigmine; Withholding Treatment	2005
Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:7 Topics: Cholinesterase Inhibitors; Comorbidity; Cross-Over Studies; Cross-Sectional Studies; Dementia; Donepezil; Double-Blind Method; Humans; Indans; Mental Status Schedule; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2005
Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs. International journal of geriatric psychiatry, 2006, Volume: 21, Issue:1 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; European Union; Galantamine; Humans; Indans; Memantine; Neurotransmitter Agents; Phenylcarbamates; Piperidines; Reimbursement Mechanisms; Rivastigmine	2006
Economic evaluation of rivastigmine in patients with Parkinson's disease dementia. PharmacoEconomics, 2006, Volume: 24, Issue:1 Topics: Aged; Canada; Cost-Benefit Analysis; Dementia; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine	2006
A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia. Drugs & aging, 2006, Volume: 23, Issue:3 Topics: Adult; Aged; Cognition; Dementia; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Pilot Projects; Prospective Studies; Risk Factors; Rivastigmine; Time Factors; Treatment Outcome; United States	2006
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:7 Topics: Aged; Alkaloids; Alzheimer Disease; Brain; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Galantamine; Geriatric Psychiatry; Health Services for the Aged; Humans; Phenylcarbamates; Professional-Family Relations; Rivastigmine; Sesquiterpenes; Tacrine; United States	2006
Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Drug Therapy, Combination; Female; Functional Laterality; Humans; Levodopa; Male; Mental Status Schedule; Neurologic Examination; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor	2006
Effect of anti-dementia drugs on LPS induced neuroinflammation in mice. Life sciences, 2007, May-01, Volume: 80, Issue:21 Topics: Acetylcholinesterase; Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Indans; Inflammation; Injections, Intraperitoneal; Interleukin-2; Lipopolysaccharides; Mice; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2007
Rivastigmine and Parkinson dementia complex. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:6 Topics: Cholinesterase Inhibitors; Dementia; Humans; Motor Activity; Parkinson Disease; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome	2007
Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:2 Topics: Activities of Daily Living; Aged, 80 and over; Alzheimer Disease; Assisted Living Facilities; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Administration Schedule; Female; Galantamine; Health Surveys; Homes for the Aged; Humans; Indans; Male; Mental Status Schedule; Neuropsychological Tests; Phenylcarbamates; Piperidines; Retention, Psychology; Rivastigmine; Survival Analysis; Treatment Outcome	2008
[Rivastigmine against dementia in Parkinson disease?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Nov-15, Volume: 127, Issue:22 Topics: Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Vomiting	2007
Identification of responders to rivastigmine: a prospective cohort study. Dementia and geriatric cognitive disorders, 2008, Volume: 25, Issue:1 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cohort Studies; Dementia; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index; Sweden	2008
Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy. Pharmacotherapy, 2008, Volume: 28, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Dementia; Down Syndrome; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Phenylcarbamates; Rivastigmine	2008
Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
A rivastigmine patch for dementia. The Medical letter on drugs and therapeutics, 2008, Mar-24, Volume: 50, Issue:1282 Topics: Administration, Cutaneous; Administration, Oral; Capsules; Cholinesterase Inhibitors; Cognition; Dementia; Drug Administration Schedule; Drug Interactions; Humans; Phenylcarbamates; Rivastigmine; Treatment Outcome	2008
Dementia medications in palliative care #174. Journal of palliative medicine, 2008, Volume: 11, Issue:4 Topics: Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Palliative Care; Phenylcarbamates; Piperidines; Prognosis; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2008
AAFP and ACP release guideline on dementia treatment. American family physician, 2008, Apr-15, Volume: 77, Issue:8 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Guidelines as Topic; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2008
Adverse reactions to rivastigmine in three cases of dementia. The Australian and New Zealand journal of psychiatry, 2001, Volume: 35, Issue:5 Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dementia; Female; Humans; Irritable Mood; Male; Phenylcarbamates; Rivastigmine; Treatment Failure	2001